Moreover, plasma levels of insulin and C-peptide, markers of hyperinsulinemia, predict risk of digestive system cancers, including colorectal, gastric, and pancreatic cancers (1,2,6,12–20). This evidence concerns the gene INS and Hyperinsulinemia.